- $1.05bn
- $925.99m
- $7.64m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 4.09 | ||
Price to Tang. Book | 5.17 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 138 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -45.75% | ||
Return on Equity | -69.46% | ||
Operating Margin | -3012.23% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | n/a | 6.2 | 7.64 | 22.35 | 121.15 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Enovix Corporation is an advanced silicon battery company. The Company’s disruptive architecture enables a battery with high energy density and capacity without compromising safety. It is engaged in designing, developing, manufacturing, and commercializing lithium-ion (Li-ion) battery cells that significantly increase the amount of energy density and storage capacity relative to conventional battery cells. Its product roadmap consists of future nodes at higher levels of energy density. In addition to designing its battery, it also develops the advanced manufacturing processes needed to produce its batteries. It uses the conventional Li-ion battery cell manufacturing techniques for processes, such as electrode coating, cell packaging, testing, and aging. It is engaged in the sale of lithium-ion batteries, electrode coating and battery pack products. The Company develops Li-ion battery cells for industrial and consumer equipment. The Company has two factories in Korea.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 23rd, 2020
- Public Since
- December 4th, 2020
- No. of Shareholders
- 114
- No. of Employees
- 560
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 168,504,136
- Address
- 3501 W. Warren Avenue, FREMONT, 94538
- Web
- https://www.enovix.com/
- Phone
- +1 6507222555
- Auditors
- Deloitte & Touche LLP
Upcoming Events for ENVX
Q1 2024 Enovix Corp Earnings Call
Enovix Corp To Host Ask Me Anything Call
Enovix Corp Annual Shareholders Meeting
Q2 2024 Enovix Corp Earnings Release
Similar to ENVX
AAON
NASDAQ Global Select Market
Advanced Energy Industries
NASDAQ Global Select Market
American Superconductor
NASDAQ Global Select Market
Astec Industries
NASDAQ Global Select Market
Cognex
NASDAQ Global Select Market
FAQ
As of Today at 19:07 UTC, shares in Enovix are trading at $6.26. This share price information is delayed by 15 minutes.
Shares in Enovix last closed at $6.26 and the price had moved by -50.47% over the past 365 days. In terms of relative price strength the Enovix share price has underperformed the S&P500 Index by -58.79% over the past year.
The overall consensus recommendation for Enovix is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Enovix does not currently pay a dividend.
Enovix does not currently pay a dividend.
Enovix does not currently pay a dividend.
To buy shares in Enovix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $6.26, shares in Enovix had a market capitalisation of $1.05bn.
Here are the trading details for Enovix:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ENVX
Based on an overall assessment of its quality, value and momentum Enovix is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Enovix is $29.73. That is 374.92% above the last closing price of $6.26.
Analysts covering Enovix currently have a consensus Earnings Per Share (EPS) forecast of -$0.98 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Enovix. Over the past six months, its share price has underperformed the S&P500 Index by -46.21%.
As of the last closing price of $6.26, shares in Enovix were trading -48.07% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Enovix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Enovix's directors